Rhone-Poulenc Rorer: Clinical Trials

6 trials sponsored by Rhone-Poulenc Rorer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 2, 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Not applicable2Completed 2
Phase 11Completed 1

Follow Rhone-Poulenc Rorer: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
Azacitidine, Entinostat, Nivolumab - Non-Small Cell Lung Cancer, Epigenetic Therapy
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins1432013-11-062024-05-03
LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
Enoxaparin - Coronary Artery Disease, Acute Myocardial Infarction
Not applicableCompletedCorewell Health East602000-03-012006-05-03
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
docetaxel - Prostate Cancer
Phase 2CompletedDana-Farber Cancer Institute191999-12-012017-07-14
Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
Docetaxel, Erythromycin Breath Test (ERMBT) - Metastatic Breast Cancer
Phase 2CompletedUniversity of Michigan Rogel Cancer Center451999-03-012012-10-05
Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
Spiramycin - Cryptosporidiosis, HIV Infections
Not applicableCompletedRhone-Poulenc Rorer2005-06-24
A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
Spiramycin - Cryptosporidiosis, HIV Infections
Phase 1CompletedRhone-Poulenc Rorer252005-06-24

Conditions studied

AIDS-Related Opportunistic Infections (2)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Cryptosporidiosis (2)  ·  Diarrhea (2)  ·  HIV Infections (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Coronary Artery Disease (1)  ·  Myocardial Infarction (1)  ·  Prostatic Neoplasms (1)

Interventions

Docetaxel (2)  ·  Spiramycin (2)  ·  Azacitidine (1)  ·  Enoxaparin (1)  ·  Nivolumab (1)  ·  entinostat (1)

Countries

United States (6)

Top investigators

Anne Schott, MD (1)  ·  Cindy L Grines, MD (1)  ·  Julie Brahmer, MD (1)  ·  Mary-Ellen Taplin, MD (1)  ·  R Soave (1)

NIH funding

P30CA006516 (1)